Stock Financial Ratios

EYES / Second Sight Medical Products, Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Price1.56
Volume438,600.00
Market Cap ($M)0.07
Enterprise Value ($M)0.07
Book Value ($M)11.15
Book Value / Share0.20
Price / Book7.49
NCAV ($M)15.28
NCAV / Share281.84
Price / NCAV5.00
Income Statement (mra) ($M)
Revenue4.00
EBITDA-33.21
Net Income-33.18
Balance Sheet (mrq) ($M)
Cash & Equivalents0.00
Cash / Share0.00
Assets0.00
Liabilities6.11
Quick Ratio2.10
Current Ratio2.70
Management Effectiveness (mra)
Return on Invested Capital (ROIC)-2.98
Return on Assets (ROA)-1.97
Return on Equity (ROE)-2.98
Identifiers and Descriptors
CUSIP81362J100
Central Index Key (CIK)1266806
Industry Groups
SIC 3845 - Electromedical and Electrotherapeutic Apparatus
Other Related CUSIPS
81362J950
81362J118
81362J900
Share Statistics
Common Shares Outstanding56,365,629
Scoring Models
Piotroski F-Score1.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Kaplan-Zingales KZ-IndexN/A
Cash Conversion CycleN/A
Per Share Metrics
Assets Other Non Current Per Share0.00
Intangibles Per Share0.00
Goodwill Per Share0.00
Accumulated Depreciation And Depletion Per Share0.00
Liabilities Per Share0.11
Assets Current Per Share0.31
Equity Per Share0.00
Liabilities Current Per Share0.00
Minority Interest Per Share0.00
Deferred Income Tax Liabilities Per Share0.00
Current Portion Of Long Term Debt Per Share0.00
Property Plant And Equipment Gross Per Share0.00
Property Plant And Equipment Per Share0.00
Inventory Raw Materials Per Share0.00
Cash And Equivalents Per Share0.00
Assets Other Current Per Share0.00
Cash Per Share0.00
Inventory Finished Goods Per Share0.00
Accounts Payable Per Share0.00
Liabilities Other Non Current Per Share0.00
Preferred Stock Value Outstanding Per Share0.00
Assets Non Current Per Share0.00
Retained Earnings Per Share0.00
Liabilities And Stock Equity Per Share0.00
Inventory Work In Progress Per Share0.00
Property Plant And Equipment Net Per Share0.00
Additional Paid In Capital Per Share0.00
Long Term Debt Per Share0.00
Treasury Stock Per Share0.00
Inventory Per Share0.06
Debt Per Share0.00
Assets Per Share0.00
Accounts Receivable Per Share0.01

Related News Stories

Second Sight (EYES) Catches Eye: Stock Jumps 12.7%

2018-02-06 zacks
Second Sight Medical Products, Inc. (EYES - Free Report) was a big mover last session, as the company saw its shares rise nearly 13% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $1.83 to $2.02 in the past one-month time frame. (80-0)

Second Sight Medical (EYES) in Focus: Stock Moves 12.1% Higher

2017-12-07 zacks
Second Sight Medical Products Inc. (EYES - Free Report) was a big mover last session, as the company saw its shares rise more than 12% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company for the company—as the stock is now up 6% in the past one-month time frame. (93-1)

Your Daily Pharma Scoop: Celgene's Upside, Regeneron Setback, AstraZeneca Submits sNDA In Japan

2017-11-27 seekingalpha
This abridged “Daily Scoop” is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. (188-3)

Second Sight Medical Products' (EYES) CEO Will McGuire on Q3 2017 Results - Earnings Call Transcript

2017-11-06 seekingalpha
Ladies and gentlemen, thank you for standing by. Welcome to the Second Sight Q3 Results Call. [Operator Instructions]. As a reminder, this conference is being recorded, Thursday, November 2st, 2017. (65-1)

BRIEF-Second Sight Medical Products reports Q3 loss per share $0.12

2017-11-02 reuters
* Second Sight Medical Products Inc - qtrly adjusted loss per share $0.11 Source text for Eikon: Further company coverage: (65-0)

CUSIP: 81362J100